Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function

NCT02225483 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2017-02-03

No results posted yet for this study

Summary

The is study will examine whether variation in clinical bleeding frequency and severity among boys with severe Hemophilia A (Factor VIII deficiency) is associated with variations in laboratory measurements of platelet activity.

Conditions

Sponsors & Collaborators

  • The Hospital for Sick Children

    collaborator OTHER
  • Novo Nordisk A/S

    collaborator INDUSTRY
  • CancerCare Manitoba

    lead OTHER

Eligibility

Min Age
3 Years
Max Age
20 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-12-31
Completion
2016-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02225483 on ClinicalTrials.gov